Northwestern Medicine Digestive Health Institute

The Gastroenterology and GI Surgery Program at Northwestern Memorial Hospital has been ranked No. 4 by @USNews, 2026 – 2027, one of the hospital's six specialties in the top five nationally.

Thank you to our team for their leading-edge research and expert patient care. breakthroughsforphysicians.nm.org/northwestern-m…

“The colorectal program at Northwestern [Medicine] is a close collaboration between gastroenterology and surgery. From straightforward benign pathologies to complex, recurrent malignancies, we are aptly positioned to care for patients who need everything from textbook treatments to clinical trials that are pushing the envelope on what is possible.” – Sowmya Narayanan, MD, PhD, Assistant Professor of Surgery, Northwestern Medicine Digestive Health Institute

Read more about Dr. Narayanan’s specialty and her thoughts on the future of medicine in this Q&A: breakthroughsforphysicians.nm.org/gastroenterolo…

#NMDigestiveHealth

Harold J. Boutte Jr., MD, spoke with @yahoo to give his expertise on which symptoms patients with IBD can track to manage their conditions effectively.

Read the article here: health.yahoo.com/conditions/dig…

#NMDigestiveHealth

Recap: The Northwestern Medicine Digestive Health Institute team attended @AASLDTweets The Liver Meeting. Spanning topics from MASLD screening to the ethics of liver donation and transplantation, the team delivered insightful presentations over the five-day conference.

Pictured presenters:
- Daniel Borja-Cacho, MD, and Andres Duarte-Rojo, MD, PhD; poster presentation on lipid signatures for fibrosis risk stratification in MASLD.
- Anjana Rajan, MD; oral presentation on hepatitis B guidelines.
- Andres Duarte-Rojo, MD, PhD; Daniel Ganger, MD; poster presentation on increased Hispanic living donor transplantation and reduced disparities – joined by Anjana Rajan, MD; Amanda Pirola, MD; Rachel Orbuch, MD.

We are honored to have taken part in this year’s conference and look forward to next year. #TLM26

How might the landmark DEGAS trial change the way gastroenterologists think about treating eosinophilic gastritis?

In this episode of Better Edge, Nirmala Gonsalves, MD, discusses findings from the trial, which evaluated dupilumab in eosinophilic gastritis (EOG). She explores the evolving understanding of Type 2 inflammation, transcriptomic remodeling and the clinical implications of the trial results for gastroenterologists.

Learn more: breakthroughsforphysicians.nm.org/gastroenterolo…

#NMDigestiveHealth